These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 379650)

  • 21. Nerve terminal components from normal and denervated Narcine electric organ.
    Hooper JE; Deutsch JW; Miljanich GP; Brasier AR; Kelly RB
    J Physiol (Paris); 1982; 78(4):443-53. PubMed ID: 7182490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A synaptic vesicle antigen is restricted to the junctional region of the presynaptic plasma membrane.
    Buckley KM; Schweitzer ES; Miljanich GP; Clift-O'Grady L; Kushner PD; Reichardt LF; Kelly RB
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7342-6. PubMed ID: 6359167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunochemical properties of junctional and extrajunctional acetylcholine receptor.
    Dwyer DS; Bradley RJ; Furner RL; Kemp GE
    Brain Res; 1981 Jul; 217(1):23-40. PubMed ID: 6167329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.
    Khedraki A; Reed EJ; Romer SH; Wang Q; Romine W; Rich MM; Talmadge RJ; Voss AA
    J Neurosci; 2017 Aug; 37(34):8077-8091. PubMed ID: 28724748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological approach to the characterization of cholinergic vesicular protein.
    Ulmar G; Whittaker VP
    J Neurochem; 1974 Mar; 22(3):451-4. PubMed ID: 4208420
    [No Abstract]   [Full Text] [Related]  

  • 27. A cholinoceptor antiserum: its pharmacological properties.
    Berti F; Clementi F; Conti-Tronconi B; Folco GC
    Br J Pharmacol; 1976 May; 57(1):17-22. PubMed ID: 179650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.
    Lang B; Newsom-Davis J; Prior C; Wray D
    J Physiol; 1983 Nov; 344():335-45. PubMed ID: 6655585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localizing properties of anti-nervous tissue antibodies in rat cervical ganglion.
    Janković BD; Mitrović K; Horvat J; Savić V
    Experientia; 1975 Feb; 31(2):239-41. PubMed ID: 46205
    [No Abstract]   [Full Text] [Related]  

  • 30. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A; Komoly S; Bózsik B; Szobor A
    Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic vesicles and microtubules in frog motor endplates.
    Gray EG
    Proc R Soc Lond B Biol Sci; 1978 Dec; 203(1152):219-27. PubMed ID: 33393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
    Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early structural changes in the motor nerve terminals of rat skeletal muscle after local injection of botulinum toxin [proceedings].
    Duxson MJ; Stolkin C
    J Physiol; 1979 Nov; 296():12P. PubMed ID: 529073
    [No Abstract]   [Full Text] [Related]  

  • 35. Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates.
    Schuetze SM; Vicini S; Hall ZW
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2533-7. PubMed ID: 2581249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular transmission after immunization against acetylcholine receptors.
    Green DP; Miledi R; Vincent A
    Proc R Soc Lond B Biol Sci; 1975 Apr; 189(1094):57-68. PubMed ID: 237278
    [No Abstract]   [Full Text] [Related]  

  • 37. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T; Prior C; Marshall IG
    J Physiol; 1991 Dec; 444():99-116. PubMed ID: 1668355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current data on acetylcholine localization in myoneural junctions and electroplax nerve].
    Israël M
    Actual Pharmacol (Paris); 1972; 25():1-22. PubMed ID: 4662645
    [No Abstract]   [Full Text] [Related]  

  • 39. Nitric oxide synthase in rat neuromuscular junctions and in nerve terminals of Torpedo electric organ: its role as regulator of acetylcholine release.
    Ribera J; Marsal J; Casanovas A; Hukkanen M; Tarabal O; Esquerda JE
    J Neurosci Res; 1998 Jan; 51(1):90-102. PubMed ID: 9452313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of prolonged repetitive stimulation in hemicholinium on the frog neuromuscular junction.
    Ceccarelli B; Hurlbut WP
    J Physiol; 1975 May; 247(1):163-88. PubMed ID: 1079538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.